Future destinations: how people cured of hepatitis C using direct acting antiviral drugs progress in a new HCV-free world. A thematic analysis by Sarah R. Donaldson, Andrew Radley, John F. Dillon

Subjects: Get full text

Efficacy of direct-acting antivirals in patients with hepatitis C virus-associated cryoglobulinemic vasculitis: Results of a long-term follow-up by S. V. Gavrisheva, D. T. Abdurakhmanov, N. M. Bulanov, E. L. Tanashhuk, T. P. Rozina, E. N. Nikulkina, S. Yu. Milovanova, E. A. Nabatchikova, A. L. Filatova, E. E. Starostina, T. N. Krasnova, S. V. Moiseev

Subjects: Get full text

Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination by Dorota Zarębska-Michaluk, Michał Brzdęk, Olga Tronina, Justyna Janocha-Litwin, Marek Sitko, Anna Piekarska, Jakub Klapaczyński, Anna Parfieniuk-Kowerda, Barbara Sobala-Szczygieł, Magdalena Tudrujek-Zdunek, Łukasz Laurans, Robert Flisiak

Subjects: Get full text

Large-scale hepatitis C combating campaigns in Egypt and Georgia; past, current and future challenges by Fatma Abdelaziz Amer

Subjects: Get full text

Interactions between Immunosuppressive Therapy and Direct-Acting Antivirals in Kidney Transplant Recipient with Hepatitis C Infection by Paolo Carta, Federica Curci, Leonardo Caroti, Larti Aida, Lorenzo Di Maria, Lino Cirami

Subjects: “…direct-acting antivirals…”
Get full text

Correspondence to editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis... by Tom Ryu, Young Chang, Seung Up Kim, Jae Young Jang

Subjects: “…direct-acting antivirals…”
Get full text

Problematic issues of the effectiveness of treatment of patients with chronic viral hepatitis C according to the State program and the ways of their solution. by L. R. Shostakovych-Koretska, O. P. Shevchenko-Makarenko, L. V. Tymofyeyeva, V. D. Tkachenko

Subjects: Get full text

HCV-related chronic kidney disease in the era of new direct-acting antivirals regimens by Jakub Janczura, Kamil Jończyk, Aleksandra Kalisz, Weronika Stepień, Łucja Ilkiewicz, Wiktoria Bisaga, Klaudia Nowak, Paweł Wróbel

Subjects: Get full text

Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C by Tom Ryu, Young Chang, Soung Won Jeong, Jeong-Ju Yoo, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Hong Soo Kim, Seung Up Kim, Jae Young Jang

Subjects: “…direct-acting antivirals…”
Get full text

Outcomes of liver transplantation in the era of modern antiviral therapy for hepatitis C by K. Yu. Kokina, Yu. O. Malinovskaya, Ya. G. Moysyuk

Subjects: Get full text

Hepatitis C Virus Infection in Hemodialysis Patients in the Era of Direct-Acting Antiviral Treatment: Observational Study and Narrative Review by Ioana Adela Ratiu, Adelina Mihaescu, Nicu Olariu, Cristian Adrian Ratiu, Bako Gabriel Cristian, Anamaria Ratiu, Mirela Indries, Simona Fratila, Danut Dejeu, Alin Teusdea, Mariana Ganea, Corina Moisa, Luciana Marc

Subjects: Get full text

PNPLA3 I148M variant is the main driver of weight gain after hepatitis C cure by V. Pitova, S. Frankova, M. Holinka, D. Merta, S. Vesela, J. A. Hubacek, M. Jirsa, J. Sperl

Subjects: Get full text

How to eliminate hepatitis C between people who inject drugs in community services and prisons in Catalonia by Elena Yela, Daniel G. Abiétar, Rafael Clua-García

Subjects: Get full text

Neuropsychiatric and laboratory outcomes of hepatitis C treatment in an early-treated HIV cohort in Thailand by Ferron Ocampo, Carlo Sacdalan, Suteeraporn Pinyakorn, Misti Paudel, Tanyaporn Wansom, Nathornsorn Poltubtim, Somchai Sriplienchan, Nittaya Phanuphak, Robert Paul, Denise Hsu, Donn Colby, Lydie Trautmann, Serena Spudich, Phillip Chan, the RV254/SEARCH 010 Study Team

Subjects: Get full text

Pharmacological interactions in novel oral anticoagulants, statins, and hypertension drugs in patients treated with direct-acting antivirals for hepatitis C: a Delphi Consensus pro... by Ivan Gentile, Giancarlo Agnelli, Angelo Avogaro, Claudio Borghi, Alessia Ciancio, Ernesto Claar, Patrizio Pasqualetti, Pasquale Perrone Filardi

Subjects: “…Direct-acting antivirals…”
Get full text

Sorafenib-treated hepatocellular carcinoma with or without prior direct-acting antiviral therapy for hepatitis C: outcomes and survival by Rania Lithy, Mohamed Kohla, Hossam Dabees, Hend Ibrahim Shousha, Ehab Fawzy, Eman M. F. Barakat, Mohamed El-Kassas, Mona Shoukry Aziz, Eman Elkhateeb, Ashraf Omar Abdelaziz, Mohamed Omar Abdelmalek, Ali Azmy, Ahmed Tawheed, Reem Abdelghafour, Hossam Taha, Mohamed Mahmoud Nabeel, Mohamed A. Medhat, Dalia Ghoraba, Hamdy Sayed, Anwar Nassief, Mostafa Elhelbawy, Tamer Elbaz, Ahmed Radwan, Safaa Ragab Askar, Eman Marwan, Eman Rewisha, Ahmed Hosni Abdelmaksoud, Sayed Hassan Ahmed, Nevien Fouad Elfouly, Nermeen Abdeen, Ahmed Ramadan, Asmaa A. Abdeltawab, Mostafa Abd Alfattah Shamkh, Yasser Arafat Abdelrazek, Ammar Alrajhi, Sayed Ahmed Sayed, Ahmed A. Sleem, Rasha Salah Hussein, Allam Elsayed Allam, Omnia A. Seyam, Mohamed Said, representing The Egyptian Network for the Study of H. C. C. (ENSH) group

Subjects: Get full text

Baseline serum EV-miR-1-3p as a protective factor and biomarker for hepatocellular carcinoma development after HCV eradication by Wei Teng, Wei-Ting Ku, Po-Ting Lin, Guan-Ting Chen, LiChieh Julie Chu, Hsuan Liu, Yung-Chang Lin, Chun-Yen Lin

Subjects: Get full text

Cost-effectiveness of antiviral therapy in treatment-naive patients with chronic hepatitis C (genotype 1) by A. V. Rudakova, D. A. Gusev, A. N. Uskov, L. N. Konovalova, Yu. V. Lobzin

Subjects: Get full text

Knowledge among patients with Hepatitis C initiating on direct-acting antiviral treatment in rural Rwanda: A prospective cohort study by Dale A Barnhart, Innocent Kamali, Francoise Nyirahabihirwe, Carol Mugabo, Jean de la Paix Gakuru, Mariam Uwase, Esdras Nizeyumuremyi, Tumusime Musafiri, Jean de Dieu Gatete, Jean Damascene Makuza, Fredrick Kateera, Bethany Hedt-Gauthier, Jean d’Amour Ndahimana

Subjects: Get full text

The politics and governance of drug production in public-private partnerships: Brazil’s response to hepatitis C by Helena de Moraes Achcar, Elize Massard da Fonseca

Subjects: Get full text